Wolverine Trading’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.75M | Sell |
93,100
-115,500
| -55% | -$10.6M | 0.01% | 1005 |
|
|
2025
Q2 | $17.9M | Buy |
208,600
+59,400
| +40% | +$5.04M | 0.02% | 506 |
|
|
2025
Q1 | $13.1M | Buy |
149,200
+44,400
| +42% | +$3.97M | 0.02% | 542 |
|
|
2024
Q4 | $8.34M | Sell |
104,800
-51,900
| -33% | -$4.49M | 0.01% | 880 |
|
|
2024
Q3 | $14M | Buy |
156,700
+98,900
| +171% | +$8.32M | 0.01% | 548 |
|
|
2024
Q2 | $4.55M | Sell |
57,800
-40,500
| -41% | -$3.32M | ﹤0.01% | 1042 |
|
|
2024
Q1 | $8.57M | Sell |
98,300
-87,100
| -47% | -$7.43M | 0.01% | 716 |
|
|
2023
Q4 | $15.3M | Buy |
185,400
+16,100
| +10% | +$1.23M | 0.02% | 543 |
|
|
2023
Q3 | $13.3M | Buy |
169,300
+16,600
| +11% | +$1.39M | 0.01% | 529 |
|
|
2023
Q2 | $13.2M | Buy |
152,700
+6,400
| +4% | +$551K | 0.02% | 491 |
|
|
2023
Q1 | $11.6M | Sell |
146,300
-9,600
| -6% | -$782K | 0.02% | 483 |
|
|
2022
Q4 | $12.1M | Buy |
155,900
+67,600
| +77% | +$5.48M | 0.02% | 549 |
|
|
2022
Q3 | $7.26M | Sell |
88,300
-6,900
| -7% | -$620K | 0.01% | 687 |
|
|
2022
Q2 | $8.61M | Sell |
95,200
-33,900
| -26% | -$3.43M | 0.01% | 573 |
|
|
2022
Q1 | $14.4M | Sell |
129,100
-68,600
| -35% | -$7.25M | 0.02% | 547 |
|
|
2021
Q4 | $20.7M | Buy |
197,700
+25,700
| +15% | +$2.98M | 0.02% | 458 |
|
|
2021
Q3 | $21.8M | Buy |
172,000
+92,100
| +115% | +$11.9M | 0.02% | 494 |
|
|
2021
Q2 | $9.95M | Sell |
79,900
-3,100
| -4% | -$389K | 0.02% | 705 |
|
|
2021
Q1 | $9.86M | Sell |
83,000
-86,900
| -51% | -$10.2M | 0.01% | 694 |
|
|
2020
Q4 | $19.6M | Sell |
169,900
-7,700
| -4% | -$848K | 0.03% | 404 |
|
|
2020
Q3 | $18.2M | Buy |
177,600
+42,900
| +32% | +$4.31M | 0.04% | 331 |
|
|
2020
Q2 | $12.2M | Sell |
134,700
-59,000
| -30% | -$5.66M | 0.03% | 394 |
|
|
2020
Q1 | $17.8M | Sell |
193,700
-40,500
| -17% | -$4.31M | 0.05% | 252 |
|
|
2019
Q4 | $26.4M | Sell |
234,200
-34,200
| -13% | -$3.75M | 0.06% | 258 |
|
|
2019
Q3 | $28.8M | Buy |
268,400
+82,000
| +44% | +$8.56M | 0.08% | 183 |
|
|
2019
Q2 | $18.2M | Sell |
186,400
-900
| -0.5% | -$82.2K | 0.05% | 319 |
|
|
2019
Q1 | $17.1M | Buy |
187,300
+21,100
| +13% | +$1.89M | 0.05% | 313 |
|
|
2018
Q4 | $14.8M | Sell |
166,200
-37,100
| -18% | -$3.47M | 0.04% | 334 |
|
|
2018
Q3 | $20M | Buy |
203,300
+4,500
| +2% | +$416K | 0.04% | 300 |
|
|
2018
Q2 | $15.9M | Hold |
198,800
| – | – | 0.04% | 325 |
|
|
2018
Q1 | $15.9M | Sell |
198,800
-47,600
| -19% | -$3.93M | 0.04% | 325 |
|
|
2017
Q4 | $19.9M | Buy |
246,400
+33,800
| +16% | +$2.71M | 0.07% | 231 |
|
|
2017
Q3 | $16.5M | Sell |
212,600
-20,200
| -9% | -$1.68M | 0.06% | 263 |
|
|
2017
Q2 | $20.7M | Buy |
232,800
+7,800
| +3% | +$658K | 0.09% | 192 |
|
|
2017
Q1 | $18.2M | Sell |
225,000
-21,500
| -9% | -$1.68M | 0.1% | 205 |
|
|
2016
Q4 | $17.6M | Sell |
246,500
-55,800
| -18% | -$4.38M | 0.09% | 238 |
|
|
2016
Q3 | $25.8M | Buy |
302,300
+75,800
| +33% | +$6.61M | 0.12% | 166 |
|
|
2016
Q2 | $19.4M | Buy |
+226,500
| New | +$18.3M | 0.11% | 178 |
|
Other funds holding MDT
Wolverine Trading's MDT Position: Q3 2025 in Review
Wolverine Trading reduced its Medtronic (MDT) stake by 61% in Q3 2025, selling an estimated $1.69M and leaving 11,650 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2804.
Wolverine Trading first reported a position in MDT in Q4 2016 and has held it in 32 quarters since. The position peaked at $14.1M in Q4 2019. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.
- Wolverine Trading held 11,650 shares of Medtronic worth $1.09M as of Q3 2025.
- Wolverine Trading sold 18,424 Medtronic shares in Q3 2025, an estimated $1.69M.
- Medtronic made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2804 holding.
- Wolverine Trading first reported a position in Medtronic in Q4 2016 and has held it in 32 quarters since.
- Wolverine Trading's Medtronic position peaked at $14.1M in Q4 2019.
- 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.